Newsstand Menu

Krainer wins 2020 NYAS Innovators prize for SMA research

photo of Adrian Krainer in his lab with Qian Zhang
Adrian R. Krainer, Ph.D., St. Giles Foundation Professor at Cold Spring Harbor Laboratory in his laboratory at Cold Spring Harbor Laboratory talking to Qian Zhang. Prof. Krainer is recognized for his research on the mechanisms and control of RNA splicing. His work led to the first drug ever approved by global regulatory bodies to delay or prevent the onset of an inherited neurodegenerative disorder. Photograph taken in January, 2020.

image of the Winter 2020 Harbor Transcript logo

Print Friendly, PDF & Email

Cold Spring Harbor Laboratory (CSHL) Professor Adrian Krainer has been named the 2020 Senior Scientist Winner of the Innovators in Science Award. Presented by the New York Academy of Sciences (NYAS) and Takeda Pharmaceuticals, the 2020 awards focus on research in rare diseases.

Krainer was chosen for his pioneering research on the mechanisms and control of RNA splicing, and in particular his work on SPINRAZA®, the novel antisense oligonucleotide therapy for spinal muscular atrophy (SMA). The treatment works to compensate for the genetic deficit that causes the disease, which is the leading genetic cause of infant mortality.

Krainer will receive the Innovators in Science Award medal and prize money at the 2020 Innovators in Science Award virtual ceremony on October 1, 2020.

Written by: Sara Roncero-Menendez, Media Strategist | | 516-367-8455

Stay informed

Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.

  Newsletter Signup